Breaking News Instant updates and real-time market news.

TEVA

Teva

$18.49

-0.78 (-4.05%)

15:00
02/13/18
02/13
15:00
02/13/18
15:00

Vote of confidence in TEVA as shares display relative weakness

Vote of confidence in TEVA as shares display relative weakness. The stock down 76c to $18.51 after competitor Novartis (NVS) received FDA approval for Glatopa. In option action, the top trade in TEVA is a 14.2K block of Jun 17.5 puts at $1.55 when bid-ask was $1.54 to 1.58. 15K trade on the day and the put writing opens positions struck 5.5% below spot and captures one earnings report in May.

TEVA Teva
$18.49

-0.78 (-4.05%)

02/13/18
WELS
02/13/18
NO CHANGE
WELS
Teva generic comes earlier than expected, says Wells Fargo
Wells Fargo analyst David Maris says Momenta Pharmaceuticals' (MNTA) generic approval of Teva Pharmaceutical's (TEVA) Copaxone came earlier than expected. As recently as the Q4 conference call on February 8, Teva management expected that another generic Copaxone approval would not come until April 2018, Maris tells investors in a research note. The analyst's forecasts assume a continued erosion of Copaxone sales, with sales of $700M in Q1, $500M sales in Q2 and $400M in Q3 and Q4. Maris keeps an Underperform rating on Teva.
02/12/18
02/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nasdaq (NDAQ) upgraded to Outperform from Market Perform at Wells Fargo by analyst Christopher Harris, who said the company is at an inflection point where both its trading and non-trading segments will begin to generate faster growth. He sees a "pathway to much higher profit margin" over the next two years and believes the stock is "relatively inexpensive" at a discount to the S&P 500 Index. 2. Teva (TEVA) upgraded to Outperform from Neutral at Credit Suisse by analyst Vamil Divan. The analyst sees "early execution" towards the company's restructuring plan and believes its 2018 outlook is achievable. He feels expectations are now reasonable believes the upside path is now clearer. 3. Cisco Systems (CSCO) upgraded to Buy from Neutral at Nomura Instinet by analyst Jeffrey Kvaal to reflect the webscale uptick and believes tax reform and the company's recurring revenue transition provide downside protection. Kvaal believes the recent pullback in Cisco shares provides a buying opportunity. 4. Tallgrass Energy Partners (TEP) upgraded to Overweight from Equal Weight at Barclays by analyst Christine Cho, who lowered her price target to $43 from $50. The analyst said her analysis suggests a Tallgrass Energy GP (TEGP) acquisition of Tallgrass Energy Partners is the most likely scenario. She valued Tallgrass Energy Partner at $43 in this scenario. 5. VF Corp (VFC) upgraded to Buy from hold at Stifel by analyst Jim Duffy, who sees fiscal 2019 consensus estimates rising throughout the year due to fundamental strength, environmental factors, and currency. Duffy believes VF shares can sustain the premium multiple for the "foreseeable future." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/12/18
FBCO
02/12/18
UPGRADE
Target $23
FBCO
Outperform
Credit Suisse upgrades Teva to Outperform amid execution on restructuring
Credit Suisse analyst Vamil Divan upgraded Teva Pharmaceutical to Outperform from Neutral and raised his price target for the shares to $23 from $20. The analyst sees "early execution" towards the company's restructuring plan and believes its 2018 outlook is achievable. He feels expectations are now reasonable believes the upside path is now clearer.
02/11/18
FBCO
02/11/18
UPGRADE
FBCO
Outperform
Teva upgraded to Outperform from Neutral at Credit Suisse

TODAY'S FREE FLY STORIES

IPXL

Impax

$19.70

0.1 (0.51%)

07:54
02/21/18
02/21
07:54
02/21/18
07:54
Hot Stocks
Amneal launches memantine hydrochloride extended-release capsules »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

PTCT

PTC Therapeutics

$24.14

0.21 (0.88%)

07:54
02/21/18
02/21
07:54
02/21/18
07:54
Recommendations
PTC Therapeutics analyst commentary  »

PTC Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

X

U.S. Steel

$44.83

0.08 (0.18%)

07:52
02/21/18
02/21
07:52
02/21/18
07:52
Recommendations
U.S. Steel analyst commentary  »

U.S. Steel price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DX

Dynex Capital

$6.28

-0.1 (-1.57%)

07:52
02/21/18
02/21
07:52
02/21/18
07:52
Earnings
Dynex Capital reports Q4 core EPS 20c, consensus 19c »

Book value per common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIA

Acacia Communications

$41.92

-0.48 (-1.13%)

07:51
02/21/18
02/21
07:51
02/21/18
07:51
Recommendations
Acacia Communications analyst commentary  »

Acacia Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 29

    Mar

RGR

Sturm, Ruger

$48.35

-1.95 (-3.88%)

, AOBC

American Outdoor Brands

$10.18

-0.56 (-5.21%)

07:50
02/21/18
02/21
07:50
02/21/18
07:50
Periodicals
President Trump urges ban of bump stocks, CNBC reports »

President Donald Trump on…

RGR

Sturm, Ruger

$48.35

-1.95 (-3.88%)

AOBC

American Outdoor Brands

$10.18

-0.56 (-5.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 01

    Mar

WYNN

Wynn Resorts

$164.92

0.64 (0.39%)

07:50
02/21/18
02/21
07:50
02/21/18
07:50
Recommendations
Wynn Resorts analyst commentary  »

Okada case could have $4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QUOT

Quotient Technology

$13.30

0.1 (0.76%)

07:49
02/21/18
02/21
07:49
02/21/18
07:49
Initiation
Quotient Technology initiated  »

Quotient Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$41.00

-1.54 (-3.62%)

, NFLX

Netflix

$278.55

0.03 (0.01%)

07:47
02/21/18
02/21
07:47
02/21/18
07:47
Periodicals
Judge rejects VW's bid to delay first U.S. diesel emissions trial, Reuters says »

A judge has denied a…

VLKAY

Volkswagen

$41.00

-1.54 (-3.62%)

NFLX

Netflix

$278.55

0.03 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 20

    Mar

MMLP

Martin Midstream Partners

$16.05

-0.2 (-1.23%)

07:47
02/21/18
02/21
07:47
02/21/18
07:47
Conference/Events
Martin Midstream Partners to hold a guidance conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

MOS

Mosaic

$26.76

1.33 (5.23%)

07:46
02/21/18
02/21
07:46
02/21/18
07:46
Technical Analysis
Technical Take: Mosaic moves higher, analyst action »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

SWDBY

Swedbank

$25.49

-0.43 (-1.66%)

07:46
02/21/18
02/21
07:46
02/21/18
07:46
Conference/Events
Swedbank management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 23

    Feb

MDR

McDermott

$7.89

0.04 (0.51%)

07:46
02/21/18
02/21
07:46
02/21/18
07:46
Earnings
McDermott sees FY18 sees FY18 EPS 42c-52c, consensus 46c »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

OKTA

Okta

$35.84

1.09 (3.14%)

07:45
02/21/18
02/21
07:45
02/21/18
07:45
Recommendations
Okta analyst commentary  »

Okta price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 07

    Mar

K

Kellogg

$69.68

0.02 (0.03%)

07:44
02/21/18
02/21
07:44
02/21/18
07:44
Hot Stocks
Kellogg affirms 2018 guidance and plan, including 2018 adjusted EPS up 9%-11% »

In slides being presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

MDR

McDermott

$7.89

0.04 (0.51%)

07:44
02/21/18
02/21
07:44
02/21/18
07:44
Earnings
McDermott reports Q4 EPS 10c, consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PTLA

Portola Pharmaceuticals

$48.22

0.53 (1.11%)

07:43
02/21/18
02/21
07:43
02/21/18
07:43
Recommendations
Portola Pharmaceuticals analyst commentary  »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 04

    May

HD

Home Depot

$186.71

-0.26 (-0.14%)

07:43
02/21/18
02/21
07:43
02/21/18
07:43
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

GPC

Genuine Parts

$94.67

-5.16 (-5.17%)

07:39
02/21/18
02/21
07:39
02/21/18
07:39
Recommendations
Genuine Parts analyst commentary  »

Genuine Parts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

OC

Owens Corning

$87.15

-0.325 (-0.37%)

07:38
02/21/18
02/21
07:38
02/21/18
07:38
Hot Stocks
Owens Corning expects FY18 corporate expenses $140M-$150M »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

FSLR

First Solar

$66.58

0.73 (1.11%)

07:37
02/21/18
02/21
07:37
02/21/18
07:37
Hot Stocks
First Solar to build 200MWac solar plant in Twiggs County, GA »

First Solar is set to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

TTS

Tile Shop

07:37
02/21/18
02/21
07:37
02/21/18
07:37
Earnings
Tile Shop reports Q4 EPS (5c), consensus 5c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WMT

Walmart

$94.11

-10.67 (-10.18%)

07:37
02/21/18
02/21
07:37
02/21/18
07:37
Recommendations
Walmart analyst commentary  »

Walmart should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

HALO

Halozyme

$18.48

-0.06 (-0.32%)

07:37
02/21/18
02/21
07:37
02/21/18
07:37
Recommendations
Halozyme analyst commentary  »

Halozyme pipeline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Apr

  • 10

    Apr

  • 11

    Apr

  • 12

    Apr

EROS

Eros International

$13.30

0.6 (4.72%)

07:36
02/21/18
02/21
07:36
02/21/18
07:36
Hot Stocks
Eros International sees reaching 6-8M paying Eros Now subscribers by March 31 »

Prem Parameswaran, Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.